Xellia's delayed factory now up and running

2020 revenue at Xellia Pharmaceuticals, a part of the Novo group, took a beating from the delayed commissioning of its US factory. Now, however, the first batch of medication has left the building.

Xellias new factory in Cleveland, Ohio, is now fully commissioned. | Photo: Xellia Pharmaceuticals / PR

After suffering from timing issues in inaugurating its factory in Cleveland, Ohio, Denmark's Xellia Pharmaceuticals has finally started production at its new facility, Xellia informs in a press statement after the firm shipped the first batch of antibiotics made at the plant, with sales directed at US hospitals.

"Xellia Cleveland is now commercially operational thanks to the hard work of our US team and employees across Xellia. Now that the site is in full working order, we will continue to ramp up our US operations to strengthen our market presence in anti-infective production and help provide the security of supply of vital drug products needed by US hospitals and patients," writes Patrick Brunner, vice president of Manufacturing Operations North America, in a press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs